Pixium Vision announces the drawdown of a further tranche, with a nominal value of €1 5 million, under the financing contract with ESGO finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Continuation of the business combination project between Pixium Vision et Second Sight Medical Products
Second
Sight ») (Nasdaq: EYES) continues under the terms announced to the market on January 6, 2021.
The company is working with Second Sight to satisfy the closing conditions to the combination, which is currently anticipated to be completed during the second quarter of 2021.
In addition, the President of the Paris Commercial Court has appointed, by order dated January 18, 2021, Mr. Olivier Péronnet and Mr. Gilles de Courcel as contribution appraiser, whose conclusions will be made available to the Pixium Vision s shareholders.
As a reminder, the completion of the transaction is notably subject to the following conditions precedent:
Investegate |Pixium Vision Announcements | Pixium Vision: Continuation of the business combination project between Pixium Vision et Second Sight Medical Products investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.